Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
Recommended Citation
Silverberg JI, Eichenfield LF, Hebert AA, Simpson E, Stein Gold LF, Bissonnette R, Papp KA, Browning J, Kwong P, Korman NJ, Brown PM, Rubenstein DS, Piscitelli SC, Somerville MC, Tallman AM, Kircik L. Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age. Br J Dermatol 2024; 190:II17-II18.
Document Type
Conference Proceeding
Publication Date
2-7-2024
Publication Title
Br J Dermatol
Volume
190
First Page
II17
Last Page
II18
